Showing results (1461-1470 of 1,520) with videos related to

Sort By:
Pageof 152
Journal of the American College of Surgeons|October 9, 2012
Retained surgical items: a problem yet to be solvedStanislaw P A Stawicki, Susan D Moffatt-Bruce, Hesham M Ahmed, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignanciesShivaani Kummar, Martin E Gutierrez, Erin R Gardner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancerNancy M Hardy, Miriam E Mossoba, Seth M Steinberg, et al.
Neuro-Oncology|April 25, 2022
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidityAndrea M Gross, Brittany Glassberg, Pamela L Wolters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in RhabdomyosarcomaSrivandana Akshintala, R Taylor Sundby, Donna Bernstein, et al.
Leukemia & Lymphoma|October 1, 2016
Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasoneElisabet E Manasanch, Carlos Fernández de Larrea, Adriana Zingone, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2019
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapyRaffit Hassan, Betsy Morrow, Anish Thomas, et al.
International Journal of Cancer|May 20, 2016
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid TumorsAnish Thomas, Christophe E Redon, Linda Sciuto, et al.
Blood Advances|February 5, 2025
Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantationMustafa A Hyder, Dimana Dimitrova, Ruby Sabina, et al.
Pageof 152